Therapeutic mechanisms of psychedelics and entactogens

BD Heifets, DE Olson - Neuropsychopharmacology, 2024 - nature.com
Recent clinical and preclinical evidence suggests that psychedelics and entactogens may
produce both rapid and sustained therapeutic effects across several indications. Currently …

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

JM Mitchell, M Ot'alora G, B van der Kolk, S Shannon… - Nature Medicine, 2023 - nature.com
This multi-site, randomized, double-blind, confirmatory phase 3 study evaluated the efficacy
and safety of 3, 4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) versus …

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions

M Alwindi, A Bizanti - Heliyon, 2023 - cell.com
Vesicular monoamine transporters (VMATs) are key regulators of neurotransmitter release
responsible for controlling numerous physiological, cognitive, emotional, and behavioral …

Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors

R Gradisch, K Schlögl, E Lazzarin, M Niello… - Nature …, 2024 - nature.com
The presynaptic serotonin transporter (SERT) clears extracellular serotonin following
vesicular release to ensure temporal and spatial regulation of serotonergic signalling and …

Dynamics of human serotonin synthesis differentially link to reward anticipation and feedback

A Hahn, MB Reed, M Murgaš, C Vraka, S Klug… - Molecular …, 2024 - nature.com
Abstract Serotonin (5-HT) plays an essential role in reward processing, however, the
possibilities to investigate 5-HT action in humans during emotional stimulation are …

Direct serotonin release in humans shapes aversive learning and inhibition

MJ Colwell, H Tagomori, F Shang, HI Cheng… - Nature …, 2024 - nature.com
The role of serotonin in human behaviour is informed by approaches which allow in vivo
modification of synaptic serotonin. However, characterising the effects of increased …

Structure–Activity Relationship of Synthetic Cathinones: An Updated Review

N Nadal-Gratacós, MD Pazos, D Pubill… - ACS Pharmacology & …, 2024 - ACS Publications
The escalating prevalence of new psychoactive substances (NPSs) poses a significant
public health challenge, evidenced by the vast chemical diversity, with over 500 substances …

[HTML][HTML] Kappa opioid receptor antagonism rescues genetic perturbation of dopamine homeostasis: Molecular, physiological and behavioral consequences

FP Mayer, A Stewart, DR Varman, AE Moritz, JD Foster… - BioRxiv, 2023 - ncbi.nlm.nih.gov
Aberrant dopamine (DA) signaling is implicated in schizophrenia, bipolar disorder (BPD),
autism spectrum disorder (ASD), substance use disorder, and attention-deficit/hyperactivity …

Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties

P Puigseslloses, N Nadal-Gratacós, G Ketsela… - Molecular …, 2024 - nature.com
Recent studies have sparked renewed interest in the therapeutic potential of psychedelics
for treating depression and other mental health conditions. Simultaneously, the novel …

Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3, 4-Methylenedioxymethamphetamine

CB Johnson, D Walther, MJ Baggott, LE Baker… - The Journal of …, 2024 - Elsevier
Methylenedioxymethamphetamine (MDMA) has shown efficacy as a medication adjunct for
treating post-traumatic stress disorder (PTSD). However, MDMA is also used in nonmedical …